[ad_1]
Should investors use the recent weakness in semiconductor stocks as a buying opportunity? Not quite yet, according to one analyst.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...